Skip to content

ENDOCURE

Active Private limited companyfounded 2022active for 4 yearsDageraadlaan 32, 1652 BeerselKBO/BCE: BE 0786.853.211

Lifetime

3 annual accounts with figures on one time axis
peak of €182,215 in 2025
€182,215▲ 220%
peak of €125,992 in 2025
€125,992▲ 489%
peak of €239,878 in 2025
€239,878▲ 111%
€42,671▲ 68.6%
Board1 name since 2022
1 director
Documentsfilings and deeds
31-08-202631 days late
2025micro format
Gross margin from €56,993 to €182,215Result from €21,377 to €125,992Equity from €113,950 to €239,878Debts from €25,312 to €42,671Cash from €85,718 to €145,516

Key points

from the 2025 annual accounts

Equity

€239,878 ▲ 111%

ENDOCURE has made a profit in every financial year since 2023.

Result

€125,992 ▲ 489%
€21,4002024€126,0002025

The result rose in 2025 from €21,377 to €125,992.

Turnover

≈ €450,000 estimated

The micro format states no turnover.

Liquidity

6.29 was 4.35 in 2024

Short-term debts rose from €25,312 to €42,671.

Filings

3 annual accounts 3 late
AprilJune31 JulyOctober202320242025

The 2023 accounts came in latest, 61 days after the end of the period.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 39,325 companies had the same profile as ENDOCURE has now. Each dot stands for 99 companies, two years later.

95.7%
were still trading
2.4%
stopped another way
1.8%
went bankrupt
  • Micro
  • 2 to 5 years old
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,760 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 39,325 companies, not a prediction for ENDOCURE. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director, since 07-06-2022
  • 100 sharesdeed of 09-06-2022
Board & ownership

Recent changes

Amendment of the articles Gazette deed
Registered office moved from Schaerbeek to Beersel The registered office moved from place Dailly 5- bte 38, 1030 Schaerbeek to Dageraadlaan 32, 1652 Beersel · Gazette deed
Registered in the Peppol Directory Reachable for e-invoices through 0208:0786853211
Incorporation Founding capital of €4,000, 100 shares · Founded by · appointed as director · published on 09-06-2022 · Gazette deed
All 12 events

Official details

Source: KBO
Status
Active since 07-06-2022Normal situation
Activity
“Alle activiteiten die op enigerlei wijze verband houden met de uitoefening van de geneeskunde,en…” (deed in French)From the articles, 2 activitiesNo NACE code in the KBO
Financial year end
31 December
Peppol
Reachable since 01-01-2026
Company details

Annual accounts 2025

€282,549▲ 103%
Filing
Filed on 31-08-2026
Financials

Insights on ENDOCURE

ENDOCURE files the micro format. That format states no turnover. The gross margin rose from €160,516 in 2023 to €182,215 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about ENDOCURE

What is the company number of ENDOCURE?
The company number of ENDOCURE is 0786.853.211. The VAT number is the same number with BE in front: BE 0786.853.211.
Where is ENDOCURE based?
The registered office is at Dageraadlaan 32, 1652 Beersel.Company details
What is the legal form of ENDOCURE?
ENDOCURE is a private limited company (BV).
When was ENDOCURE founded?
ENDOCURE was founded on 07-06-2022.
Is ENDOCURE still active?
Yes, ENDOCURE is an active enterprise in the KBO register.
What is the turnover of ENDOCURE?
The turnover in financial year 2025 is ≈ €450,000. This figure is estimated from the gross margin of €182,215 and 2,459 comparable companies of the same size. It probably lies between €300,000 and €710,000. It is a rough estimate.Financials
Is ENDOCURE profitable?
In financial year 2025, ENDOCURE made a profit of €125,992.
Where can I find the annual accounts of ENDOCURE?
ENDOCURE filed 3 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of ENDOCURE due?
ENDOCURE must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.